Search results
Results from the WOW.Com Content Network
Credé prophylaxis is the practice of washing a newborn's eyes with a 2% silver nitrate solution to protect against neonatal conjunctivitis caused by Neisseria gonorrhoeae, thereby preventing blindness. [1] The Credé procedure was developed by the German physician Carl Siegmund Franz Credé who implemented it in his hospital in Leipzig in 1880 ...
Thus, prophylaxis with a 1% silver nitrate solution is no longer in common use. [7] In most countries, neomycin and chloramphenicol eye drops are used, instead. [8] [9] However, newborns can develop neonatal conjunctivitis due to reactions with chemicals in these common eye drops. [10]
Since the adoption of this prophylactic treatment, infant mortality from GBS infection has decreased by 80%. [36] Mothers with symptomatic genital herpes and who are treated with antiviral prophylaxis are less prone to have an active, symptomatic case at the time of birth and it may be able to reduce the risk of passing on HSV during birth ...
Find a list of recalled drops in 2023. Plus, eye infection symptoms. Eye drops are being recalled due to a rare bacterium found in artificial tears. Find a list of recalled drops in 2023.
Eye drops or eyedrops are liquid drops applied directly to the surface of the eye usually in small amounts such as a single drop or a few drops. Eye drops usually contain saline to match the salinity of the eye. Drops containing only saline and sometimes a lubricant are often used as artificial tears to treat dry eyes or simple eye irritation ...
While it's not technically an eye drop product, implicated tubes of ointment (which is used on skin in proximity to the eye) can be identified with the NDC 72570-122-35 and UPC code 3 72570 12235 3.
Chloramphenicol is an antibiotic useful for the treatment of a number of bacterial infections. [5] This includes use as an eye ointment to treat conjunctivitis. [6] By mouth or by injection into a vein, it is used to treat meningitis, plague, cholera, and typhoid fever. [5]
The CDC said recalled EzriCare and other eyedrops have been linked to more deaths and vision loss because rare bacterial infections.